Trending:
News
-
12 December 2018
Roche, Merck partner to develop pan-cancer companion diagnostic test
Roche has teamed up with Merck to develop a pan-cancer companion diagnostic to identify advanced solid tumour patients who are eligible for anti-PD-1 therapy.
-
12 December 2018
Cerenovus launches global thrombectomy registry in US and Europe
Cerenovus, a part of Johnson & Johnson Medical Devices Companies, has launched a new registry to gather and examine stroke-inducing blood clots removed from the brain with its EMBOTRAP II...
-
11 December 2018
Olympus Medical to pay $85m to settle probe in US
Olympus Medical Systems, a unit of Japan’s Olympus, has pleaded guilty and agreed to pay $85m to resolve a criminal probe by the US Department of Justice (DOJ) over infection...
-
11 December 2018
Bay Labs, Edwards Lifesciences sign AI heart disease detection deal
Medical technology firm Bay Labs has partnered with medical equipment provider Edwards Lifesciences to bolster the detection of heart disease using artificial intelligence (AI) software.
-
11 December 2018
Sandoz and Pear Therapeutics get FDA clearance for reSET-O app
Novartis subsidiary Sandoz and Pear Therapeutics have obtained US Food and Drug Administration (FDA) 510(k) clearance for the use of the reSET-O mobile application, which treats opioid use disorder (OUD).
-
10 December 2018
Researchers to develop blood test for Alzheimer’s disease
Researchers at Brigham and Women's Hospital in the US are working on the development of a blood test to accurately diagnose and potentially predict Alzheimer's disease before the appearance of...
-
10 December 2018
Researchers create less-invasive biosensor for breast cancer diagnosis
A research team funded by the US National Institute of Biomedical Imaging and Bioengineering (NIBIB) has devised a new biosensor to diagnose breast cancer less invasively compared to the existing...
-
10 December 2018
FDA clears Contego’s Vanguard balloon angioplasty system
Medical devices firm Contego Medical has received the US Food and Drug Administration (FDA) 510(k) clearance for the Vanguard IEP Peripheral Balloon Angioplasty System, which treats peripheral vascular disease.
-
7 December 2018
RCS report highlights tech that will drive the future of surgery
The Royal College of Surgeons’ independent Commission on the Future of Surgery has predicted that surgery is set to be transformed for millions of patients due to an influx of...
-
7 December 2018
US researchers study use of graphene to detect ALS
University of Illinois researchers have conducted a study to evaluate the potential use of graphene in identifying amyotrophic lateral sclerosis (ALS), a neurodegenerative disease.